Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 62 5
Convalescent plasma Emergency use authorization Experimental Antiviral Apr/10/2021 37 6
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
CoronaVac Potential treatment - clinical evidence Experimental Vaccine Apr/06/2021 4 1
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 9 0
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/08/2021 15 2
FN3D Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
FN3A Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0
FN3B Potential treatment - pre-clinical evidence Experimental Antiviral Feb/05/2021 1 0